A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent prostate cancer

被引：0
|
作者：
Nyati, Shyam
Stricker, Hans
Barton, Kenneth L.
Li, Piln
Elshaikh, Mohamed
Ali, Haythem
Brown, Stephen L.
Hwang, Clara
Peabody, James
Freytag, Svend O.
Movsas, Benjamin
Siddiqui, Farzan
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2023-CT196
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT196
引用
收藏
页数：2
相关论文
共 50 条
  • [1] A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma
    Nyati, Shyam
    Stricker, Hans
    Barton, Kenneth N.
    Li, Pin
    Elshaikh, Mohamed
    Ali, Haythem
    Brown, Stephen L.
    Hwang, Clara
    Peabody, James
    Freytag, Svend O.
    Movsas, Benjamin
    Siddiqui, Farzan
    [J]. PLOS ONE, 2023, 18 (09):
  • [2] Phase I trial of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for the treatment of metastatic pancreatic cancer
    Barton, Kenneth N.
    Siddiqui, Farzan
    Pompa, Robert
    Freytag, Svend O.
    Khan, Gazala
    Dobrosotskaya, Irina
    Ajlouni, Munther
    Zhang, Yingshu
    Cheng, Jingfang
    Movsas, Benjamin
    Kwon, David
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2021, 20 : 94 - 104
  • [3] Preclinical toxicology of oncolytic adenovirus-mediated cytotoxic and interleukin-12 gene therapy for prostate cancer
    Freytag, Svend O.
    Zhang, Yingshu
    Siddiqui, Farzan
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2015, 2 : 15006
  • [4] Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
    Freytag, S. O.
    Barton, K. N.
    Zhang, Y.
    [J]. GENE THERAPY, 2013, 20 (12) : 1131 - 1139
  • [5] Efficacy of oncolytic adenovirus expressing suicide genes and interleukin-12 in preclinical model of prostate cancer
    S O Freytag
    K N Barton
    Y Zhang
    [J]. Gene Therapy, 2013, 20 : 1131 - 1139
  • [6] A phase I/II study of adenovirus-mediated interleukin-12 gene therapy for hormone refractory prostate cancer: An interim report
    Sasaki, K.
    Nasu, Y.
    Kaku, H.
    Watanabe, M.
    Nose, H.
    Kanbara, D.
    Saika, T.
    Kumon, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [7] Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer
    Bhatnagar, Aseem Rai
    Siddiqui, Farzan
    Khan, Gazala
    Pompa, Robert
    Kwon, David
    Nyati, Shyam
    [J]. BIOMEDICINES, 2024, 12 (05)
  • [8] Replication Competent Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy in Prostate Cancer: 36-month Follow-Up Data from a Phase I Clinical Trial
    Nyati, Shyam
    Stricker, Hans
    Barton, Kenneth N.
    Li, Pin
    Elshaikh, Mohamed
    Ali, Haythem
    Brown, Stephen L.
    Hwang, Clara
    Peabody, James
    Freytag, Svend O.
    Movsas, Benjamin
    Siddiqui, Farzan
    [J]. MOLECULAR THERAPY, 2023, 31 (04) : 297 - 297
  • [9] A PHASE I/II STUDY OF ADENOVIRUS-MEDIATED INTERLEUKIN-12 GENE THERAPY FOR HORMONE REFRACTORY PROSTATE CANCER; A REPORT OF INITIAL 6 CASES
    Sasaki, Katsumi
    Nasu, Yasutomo
    Kaku, Haruki
    Watanabe, Masami
    Edamura, Kohei
    Saika, Takashi
    Kumon, Hiromi
    Brenner, Malcolm K.
    [J]. JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1025 - 1025
  • [10] Phase I trial of replication-competent adenovirus-mediated suicide gene therapy combined with IMRT for prostate cancer
    Freytag, Svend O.
    Movsas, Benjamin
    Aref, Ibrahim
    Stricker, Hans
    Peabody, James
    Pegg, Jan
    Zhang, Yingshu
    Barton, Kenneth N.
    Brown, Stephen L.
    Lu, Mei
    Savera, Adnan
    Kim, Jae Ho
    [J]. MOLECULAR THERAPY, 2007, 15 (05) : 1016 - 1023
12345